New York Attorney General Letitia James says the state's Medicaid program will receive over $2.25 million as part of a $36.5 million multi-state settlement with CVS. 37 states and the U.S. Department of Justice secured the agreement on Tuesday after the pharmacy chain allegedly fraudulently overbilled Medicaid for insulin prescriptions from 2010-2020. The coalition of attorneys general say CVS knowingly dispensed more insulin to customers than they needed while maintaining that they were reporting the correct amount of insulin in their prescriptions. These fraudulent claims allowed the company to rake in millions in extra reimbursements from Medicaid for insulin distribution. Under the settlement, CVS will pay more than $25 million to state Medicaid programs across the country.
